Preferred Term:
anti-obesity agents
Definition:
Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity.
Concept Schemes:
NALT Full
Broader Concept:
Narrower Concepts:
Entry Terms:
- weight-loss drugs
- weight-loss agents
- weight-reducing drugs
URI:
https://lod.nal.usda.gov/nalt/291608
Download this Concept:
RDF/XMLCreated 2017-02-07, last modified 2020-07-20